Castle Biosciences, Indiana University Research and Technology deal

Castle received exclusive, worldwide rights from the not-for-profit to IP related to the biotech's DecisionDx-Thymoma test to detect the likelihood of metastasis in thymic cancer. Details were not disclosed. ...